Biotech: Page 33
-
PharmaVoice Team/PharmaVoice
The Education of Principal Investigators
Efforts by pharma companies and other organizations aim to standardize GCP and training requirements for clinical research investigators and sites. Principal investigators and clinical sites are the backbone of clinical research. Sponsors and CROs depend on investigators and sites to conduct stud...
By Denise Myshko • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
New Models for Academic Partnerships
Academic medical centers have a renewed interest in partnering with pharmaceutical companies and are investing resources to ensure successful collaborations. Industry partnerships with universities are changing. These collaborations are no longer about single projects. They are broader in scope, ...
By Denise Myshko • Sept. 27, 2014 -
Explore the Trendline➔
Stock via Getty Images
TrendlineCommercialization, marketing and social media
As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
The Nanomedicine Revolution
Nanomedicines have the potential to improve effectiveness and reduce the side effects of therapeutics. Nanotechnology has the potential to revolutionize healthcare across disciplines and specialties. For medicines specifically, nanotechnology can improve drug targeting and effectiveness and reduc...
By Denise Myshko • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
In the Pharmacy
As pharmacists’ roles expand to near provider status, new opportunities for partnerships open up for pharma. Over the years, pharmacists’ duties have been expanding, but recent legislative acts and regulations are providing the stimulus for an even more robust role. Pharmacists are becoming full ...
By Robin Robinson • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
Last Word
The HBA Turns 35 Laurie Cooke, CEO of the Healthcare Businesswomen’s Association (HBA), discusses the organization’s strategic mission for the future as it celebrates its 35th anniversary. PV: The HBA was originally conceptualized 37 years ago by five women and became an official nonprofit orga...
By Laurie Cooke • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
The Rise of Biosimilars
The promise of biosimilars is to provide cost-savings, increased patient access, and promote innovation. The biotechnology market in the United States is about to be altered significantly. In July, Sandoz announced it was the first company to file an application under the biosimilars pathway crea...
By Denise Myshko • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
Last Word
Collaborating for a Cure Walter Capone, President of the Multiple Myeloma Research Foundation, talks about data sharing, open access to research, and how collaborative research can lead to new therapies. PV: How did the open access data portal, the MMRF Researcher Gateway, get started? CAPONE: T...
By Walter Capone • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma Pool DR. JOHN ORLOFF Baxter Appoints VP of BioScience R&D Baxter International has appointed John Orloff, M.D., as VP and global head of research and development for Baxter BioScience. Dr. Orloff joins Baxter from Merck Serono Pharmaceuticals, where he served as global head of clinical...
By Ann Grey • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
Social Buzz
A collection of social media news, events, and strategies. Trending now: Mobile technology improves patient outcomes. A randomized control trial conducted through the Montefiore Medical Center earlier this year found a significant improvement in a number of key patient engagement metrics when car...
By Taren Grom • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
Innovator's Corner
A Single Pill for Multiple Viruses The treatment of viral infections is an unmet medical need. While many viruses such as rhinoviruses, which cause the cold, are not considered serious, others, such as ebola, are. There are more than 200 viruses that cause mild-to-severe diseases that have limite...
By Lillian Chiang • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
PharmaVOICE 100 - Who's on the List by Section
These extraordinary leaders, representing a wide range of industry sectors and functional areas of expertise, are having a positive impact on their colleagues, their companies, and the greater healthcare community. See who you know! Who’s on the List — 2014 Indexed by Section The Academics Dr. Mo...
By Taren Grom • July 28, 2014 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
Veeva Systems Introduces Commercial Cloud for Life Sciences Trending Now: New industry cloud brings together master data, compliant content, and customer interactions across all channels to transform commercial operations. Veeva Systems has unveiled Commercial Cloud, a next-generation solution to...
By Denise Myshko • July 28, 2014 -
PharmaVoice Team/PharmaVoice
What's New
Global Outcomes Group Launches to Support Outcomes Research Trending Now: New full-service medical communications agency focuses on supporting growing health economics and outcomes research in biopharma industry. The Global Outcomes Group has been formed to support the content and communication n...
By Denise Myshko • July 28, 2014 -
PharmaVoice Team/PharmaVoice
2014 PharmaVOICE 100 - Who's on the List by Company
Who’s on the List — 2014 Indexed by Company Affiliation AbelsonTaylor – Dr. Jeffrey Berg Advanced Clinical LLC – Susan Seroskie Advanced Clinical LLC – Julie Ross Baxter Healthcare Corp. – John Glasspool BBK Worldwide – Aaron Fleishman BioClinica Inc. – Dr. Boaz Mendzelevski Biogen Idec – Dr. Kat...
By Robin Robinson • July 28, 2014 -
PharmaVoice Team/PharmaVoice
UpFront
INDUSTRY at Large Kowa and Football Player Help those with High Cholesterol Kowa Pharmaceuticals America has announced a partnership with Kurt Warner, Super Bowl winner and two-time NFL MVP, and his wife Brenda, to launch First and Goal, a national education initiative to help people prioritize h...
By Denise Myshko • July 28, 2014 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
The 2014 PharmaVOICE 100 The PharmaVOICE 100 Turns 10! It’s hard to believe that 10 years after the vision for this issue was captured on the back of a napkin during a long flight delay, we have now profiled 1,000 of the industry’s most inspirational and motivational individuals making this issue...
By Taren Grom • July 28, 2014 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Clinical Trial Solutions: The Upside of Clinical Solutions
Even as pharmaceutical companies and their development partners continue to grapple with bringing safe products to market on time and on budget, new technologies, models, and analytics are driving improvements to counter the industry’s challenges. According to R&D leaders who recently partici...
By PharmaVoice Team • May 29, 2014 -
PharmaVoice Team/PharmaVoice
Thailand Makes Great Strides in Healthcare
With a growing pharmaceutical market, renowned biotechnology research programs, and strong government support for the industry, Thailand has much to recommend it to the global pharma industry. The Kingdom of Thailand, a country with a population of 70 million people, is regarded as newly industri...
By Kim Ribbink • May 29, 2014 -
PharmaVoice Team/PharmaVoice
Talent Pool
Talent Pool executive appointments and promotions in the healthcare industry Pharma Pool DR. UDIT BATRA EMD Millipore Introduces CEO and President EMD Millipore, the life-sciences division of Merck KGaA, has appointed Udit Batra, Ph.D., as president and CEO, responsible for the organization’s str...
By Ann Grey • May 29, 2014 -
PharmaVoice Team/PharmaVoice
On the Calendar
The Calendar Industry Events and Conferences, including Special Discounts Coming Attractions This year marks the 50th Anniversary of the DIA Annual Meeting, the largest multidisciplinary event that brings together a global network of life-sciences professionals to foster innovation that will lead...
By Heather Hummel • May 29, 2014 -
PharmaVoice Team/PharmaVoice
Malaysia Focuses on Growth with Healthcare a Top Priority
Malaysia presents an attractive market to pharmaceutical companies thanks to growing government support, good infrastructure, and a trusted manufacturing environment. Malaysia is a federal constitutional monarchy with a population of about 29 million and an open and growing economy. According to ...
By Kim Ribbink • April 28, 2014 -
PharmaVoice Team/PharmaVoice
HBA's 2014 Rising Stars
Joyce Acbay Senior Director, Regulatory Affairs Actelion Pharmaceuticals Joyce is passionate about mentoring women and helping others reach their professional goals. Lorrie Albinson Associate Director, Sales Training and Development Actavis Brand Sales Actavis Lorrie is a distinguished leader at ...
By Taren Grom • April 28, 2014 -
PharmaVoice Team/PharmaVoice
Pharma Doors Begin to Open in Indonesia
Pharma Doors Begin to Open in Indonesia By Kim Ribbink Though many challenges continue for pharma companies bringing products to market in Indonesia, a growing middle class and improving healthcare access make it a desirable market. Indonesia is the world’s fourth largest country in terms of popu...
By Kim Ribbink • March 27, 2014 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma Pool Albert BOURLA Susan SILBERMANN Pfizer Makes Executive Moves Pfizer has named Albert Bourla as group president of the vaccines, oncology, and consumer healthcare business. Mr. Bourla has 20 years of experience at Pfizer and has held senior global positions across a range of markets and...
By Ann Grey • Feb. 25, 2014 -
PharmaVoice Team/PharmaVoice
On the Calendar
On the Calendar The Calendar Industry Events and Conferences, including special discounts Coming Attractions In May 2014, the Healthcare Businesswomen’s Association is celebrating the 25th anniversary of its prestigious Woman of the Year (WOTY) award. The HBA is proud to announce that three vis...
By Heather Hummel • Feb. 25, 2014
Previous
